205 related articles for article (PubMed ID: 18281504)
1. Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II.
He L; Giri TK; Vicente CP; Tollefsen DM
Blood; 2008 Apr; 111(8):4118-25. PubMed ID: 18281504
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice.
Vicente CP; He L; Pavão MS; Tollefsen DM
Blood; 2004 Dec; 104(13):3965-70. PubMed ID: 15315969
[TBL] [Abstract][Full Text] [Related]
3. N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfate.
Halldórsdóttir AM; Zhang L; Tollefsen DM
Glycobiology; 2006 Aug; 16(8):693-701. PubMed ID: 16624894
[TBL] [Abstract][Full Text] [Related]
4. Active site for heparin cofactor II in low molecular mass dermatan sulfate. Contribution to the antithrombotic activity of fractions with high affinity for heparin cofactor II.
Mascellani G; Liverani L; Parma B; Bergonzini G; Bianchini P
Thromb Res; 1996 Oct; 84(1):21-32. PubMed ID: 8885144
[TBL] [Abstract][Full Text] [Related]
5. Site-directed mutagenesis of arginine 103 and lysine 185 in the proposed glycosaminoglycan-binding site of heparin cofactor II.
Blinder MA; Tollefsen DM
J Biol Chem; 1990 Jan; 265(1):286-91. PubMed ID: 2104620
[TBL] [Abstract][Full Text] [Related]
6. Arterial smooth muscle cell heparan sulfate proteoglycans accelerate thrombin inhibition by heparin cofactor II.
Shirk RA; Church FC; Wagner WD
Arterioscler Thromb Vasc Biol; 1996 Sep; 16(9):1138-46. PubMed ID: 8792767
[TBL] [Abstract][Full Text] [Related]
7. Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans.
Sheehan JP; Tollefsen DM; Sadler JE
J Biol Chem; 1994 Dec; 269(52):32747-51. PubMed ID: 7806495
[TBL] [Abstract][Full Text] [Related]
8. Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II.
Liaw PC; Austin RC; Fredenburgh JC; Stafford AR; Weitz JI
J Biol Chem; 1999 Sep; 274(39):27597-604. PubMed ID: 10488098
[TBL] [Abstract][Full Text] [Related]
9. The interaction of glycosaminoglycans with heparin cofactor II: structure and activity of a high-affinity dermatan sulfate hexasaccharide.
Tollefsen DM
Adv Exp Med Biol; 1992; 313():167-76. PubMed ID: 1442260
[TBL] [Abstract][Full Text] [Related]
10. Activation of heparin cofactor II by fibroblasts and vascular smooth muscle cells.
McGuire EA; Tollefsen DM
J Biol Chem; 1987 Jan; 262(1):169-75. PubMed ID: 3793724
[TBL] [Abstract][Full Text] [Related]
11. Accelerated atherogenesis and neointima formation in heparin cofactor II deficient mice.
Vicente CP; He L; Tollefsen DM
Blood; 2007 Dec; 110(13):4261-7. PubMed ID: 17878401
[TBL] [Abstract][Full Text] [Related]
12. Heparin cofactor II modulates the response to vascular injury.
Tollefsen DM
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):454-60. PubMed ID: 17194895
[TBL] [Abstract][Full Text] [Related]
13. Heparin cofactor II inhibits arterial thrombosis after endothelial injury.
He L; Vicente CP; Westrick RJ; Eitzman DT; Tollefsen DM
J Clin Invest; 2002 Jan; 109(2):213-9. PubMed ID: 11805133
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice.
Langford-Smith K; Arasaradnam M; Wraith JE; Wynn R; Bigger BW
Mol Genet Metab; 2010 Mar; 99(3):269-74. PubMed ID: 19926322
[TBL] [Abstract][Full Text] [Related]
15. Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II.
Giri TK; Tollefsen DM
Blood; 2006 Apr; 107(7):2753-8. PubMed ID: 16339402
[TBL] [Abstract][Full Text] [Related]
16. Thrombin inhibition by HCII in the presence of elastase-cleaved HCII and thrombin-HCII complex.
Maekawa H; Sato H; Tollefsen DM
Thromb Res; 2000 Dec; 100(5):443-51. PubMed ID: 11150588
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of thrombin inhibition by heparin cofactor II and antithrombin in the presence of the ray (Raja radula) skin dermatan sulfate.
Ben Mansour M; Dhahri M; Vénisse L; Jandrot-Perrus M; Chaubet F; Maaroufi RM
Thromb Res; 2009 Apr; 123(6):902-8. PubMed ID: 19046760
[TBL] [Abstract][Full Text] [Related]
18. Vascular dermatan sulfate and heparin cofactor II.
Tollefsen DM
Prog Mol Biol Transl Sci; 2010; 93():351-72. PubMed ID: 20807652
[TBL] [Abstract][Full Text] [Related]
19. Dermatan sulfate is the predominant antithrombotic glycosaminoglycan in vessel walls: implications for a possible physiological function of heparin cofactor II.
Tovar AM; de Mattos DA; Stelling MP; Sarcinelli-Luz BS; Nazareth RA; Mourão PA
Biochim Biophys Acta; 2005 Apr; 1740(1):45-53. PubMed ID: 15878740
[TBL] [Abstract][Full Text] [Related]
20. Heparin cofactor IIOslo. Mutation of Arg-189 to His decreases the affinity for dermatan sulfate.
Blinder MA; Andersson TR; Abildgaard U; Tollefsen DM
J Biol Chem; 1989 Mar; 264(9):5128-33. PubMed ID: 2647747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
